BAY.TI - AZIONI

TLO - TLO Delayed Price. Currency in EUR
61.04
-0.49 (-0.80%)
At close: 4:59PM CEST
Stock chart is not supported by your current browser
Previous Close61.53
Open61.59
Bid0.00 x 40000
Ask0.00 x 40000
Day's Range60.93 - 61.59
52 Week Range60.93 - 61.59
Volume1,346
Avg. VolumeN/A
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Barrons.com9 hours ago

    ‘Goodwill’ Write-offs Are an Earnings Killer. How to Spot Trouble Coming.

    Companies write off “goodwill” when the value of acquired assets declines. It happened at Kraft Heinz and GE. Keep an eye on Bayer and Cigna next.

  • Bayer says to comply with court mediation order in glyphosate case
    Reuters6 days ago

    Bayer says to comply with court mediation order in glyphosate case

    Bayer said on Friday it would comply with a U.S. federal judge's order to enter mediation with a plaintiff who claims the company failed to warn against an alleged cancer risk from its Roundup weedkiller. Bayer has seen billions wiped off its market value since August, when a first U.S. jury found Bayer liable because Monsanto, acquired by Bayer for $63 billion last year, had not warned of the alleged risk from Roundup, which is based on active ingredient glyphosate. U.S. District Judge Vince Chhabria, who presided over the first two cases in federal court, said in a filing dated Thursday that Bayer and another plaintiff, Elaine Stevick, were ordered to start confidential mediation.

  • Reuters7 days ago

    French court finds Bayer's Monsanto liable for farmer's sickness

    PARIS/LYON (Reuters) - A French court has ruled that Monsanto was liable for the sickness of a farmer who inhaled one of its weedkillers, in another legal setback for the Bayer-owned business over health claims. In the latest stage of a decade-long legal tussle, the appeals court in Lyon on Thursday found in favour of farmer Paul Francois' claim that Monsanto's Lasso weedkiller had made him sick and that the product's labelling had been inadequate. "Mr Francois justifiably concludes that the product, due to its inadequate labelling that did not respect applicable regulations, did not offer the level of safety he could legitimately expect," the court said in its ruling.

  • Reuters7 days ago

    U.S. criticizes Vietnam ban of glyphosate herbicide imports

    Vietnam's government said in a statement that the toxic level of herbicides containing glyphosate had long been of concern, in the latest display of global worries over the product's impact on human health. Glyphosate, the chemical contained in Bayer AG's best-selling weed killer Roundup, is the target of thousands of lawsuits in the United States alleging exposure to it causes cancer. Roundup, which Bayer acquired with its $63 billion purchase of Monsanto last year, was the first to contain glyphosate, the world's most widely used weed killer.

  • Reuters7 days ago

    Bayer considers legal options after French court rules for farmer

    German chemical group Bayer said it was considering its legal options, including an appeal, after a French court ruled in favour of a farmer who blamed a weedkiller of Bayer's Monsanto unit for health problems. Thursday's ruling by an appeals court in Lyon in southeast France was the latest stage in a decade-long legal tussle between Monsanto and farmer Paul Francois, who says he fell ill after inhaling weedkiller Lasso in 2004.

  • CEO sees Bayer 'massively' affected by herbicide litigation
    Reuters7 days ago

    CEO sees Bayer 'massively' affected by herbicide litigation

    Bayer's chief executive on Thursday acknowledged the German maker of pharmaceuticals and crop chemicals was facing massive challenges from a wave of lawsuits over an alleged carcinogenic effect of its Roundup weedkiller. You see it in our share price," CEO Werner Baumann said in a panel discussion at an academic business event in Cologne. Bayer has seen about 30 billion euros ($34 billion) wiped off its market value since August, when a U.S. jury found Bayer liable because Monsanto, acquired by Bayer for $63 billion last year, had not warned of weedkiller Roundup's alleged cancer risks.

  • Bayer shareholder Deka joins chorus of complaints over Monsanto
    Reuters8 days ago

    Bayer shareholder Deka joins chorus of complaints over Monsanto

    One of Bayer's largest shareholders tore into the company's management on Wednesday for underestimating the legal risks of its takeover of Monsanto, setting the stage for a fiery annual general meeting after a 30 percent plunge in the shares. Bayer has seen about 30 billion euros ($34 billion) wiped off its market value since August, when a U.S. jury found Bayer liable because Monsanto had not warned of weedkiller Roundup's alleged cancer risks. There can be no talk of a successful takeover any more," Ingo Speich, the head of sustainability and corporate governance at Deka Investment, told Reuters.

  • Associated Press9 days ago

    Pharmaceuticals giant Bayer to cut 4,500 jobs in Germany

    BERLIN (AP) — Pharma and chemicals giant Bayer says it is cutting 4,500 jobs in its home market of Germany.

  • Morningstar10 days ago

    We See Steady Growth for Bayer

    Largely on the basis of the strong competitive advantages of the healthcare group and to a lesser extent the crop science business, we believe  Bayer BAYRY has created a wide economic moat. Also, the recent divestiture of no-moat material science group Covestro leaves the company in a stronger competitive position. In the healthcare division, Bayer's strong lineup of recently launched drugs and solid exposure to biologics should support steady long-term growth.

  • Novozymes gets more partners for bio-agriculture arm beyond Bayer
    Reuters13 days ago

    Novozymes gets more partners for bio-agriculture arm beyond Bayer

    Novozymes has signed up two new partners for its biological agriculture business (BioAg), adding to its previously exclusive partnership with German chemicals giant Bayer in a drive to boost growth. The Danish company is the world's largest maker of industrial enzymes and with BioAg produces microbes such as bacteria and fungi to protect plants from pests and help them to grow faster. It will continue a close innovation and commercial partnership with Bayer within corn and soy, Novozymes said late on Thursday, as it presented two new partners - Univar Solutions and UPL.

  • Bayer contains cyber attack it says bore Chinese hallmarks
    Reuters14 days ago

    Bayer contains cyber attack it says bore Chinese hallmarks

    German drugmaker Bayer has contained a cyber attack it believes was hatched in China, the company said, highlighting the risk of data theft and disruption faced by big business. Bayer found the infectious software on its computer networks early last year, covertly monitored and analysed it until the end of last month and then cleared the threat from its systems, the company said on Thursday. "There is no evidence of data theft," Bayer said in a statement, though a spokesman added that the overall damage was still being assessed and that German state prosecutors had launched an investigation.

  • Reuters14 days ago

    Bayer chairman backs management's strategy - Handelsblatt

    Bayer's supervisory board fully supports the company's management regarding its strategy, including the acquisition of Monsanto, Chairman Werner Wenning told business daily Handelsblatt on Thursday. The company's executive board had assessed all risks related to Monsanto and its glyphosate weedkiller in "a most professional" way and fulfilled all relevant legal requirements, Wenning was cited as saying. Company filings showed this week that the supervisory board sought law firm Linklaters' expert opinion for reassurance that the management board had complied with their duties when acquiring Monsanto for $63 billion last year.

  • Bayer chairman backs management's strategy: Handelsblatt
    Reuters14 days ago

    Bayer chairman backs management's strategy: Handelsblatt

    Bayer's supervisory board fully supports the company's management regarding its strategy, including the acquisition of Monsanto, Chairman Werner Wenning told business daily Handelsblatt on Thursday. The company's executive board had assessed all risks related to Monsanto and its glyphosate weedkiller in "a most professional" way and fulfilled all relevant legal requirements, Wenning was cited as saying. Company filings showed this week that the supervisory board sought law firm Linklaters' expert opinion for reassurance that the management board had complied with their duties when acquiring Monsanto for $63 billion last year.

  • Associated Press14 days ago

    German chemicals giant Bayer confirms cyberattack

    BERLIN (AP) — German chemicals company Bayer says it detected and averted a cyberattack last year by a hacking group that's been traced to China.

  • Bayer Mounts Damage-Control Effort After Roundup Verdicts
    Bloomberg15 days ago

    Bayer Mounts Damage-Control Effort After Roundup Verdicts

    Chief Executive Officer Werner Baumann held a conference call with employees around the world on Monday, assuring them that the 155-year-old German company will weather the challenge despite a second loss in U.S. courts, according to people familiar with the situation. Investor trust in Baumann is slipping, with proxy adviser Glass Lewis & Co. questioning his bonus and urging a vote of no confidence in him and other executives at Bayer’s annual meeting later this month. The internal damage-control initiative comes as Baumann prepares for the April 26 meeting of shareholders angry at how the company’s fortunes have faltered since it completed the $63 billion acquisition of Roundup owner Monsanto last June.

  • Barrons.com16 days ago

    You Can Play the Flurry of M&A With Merger Arbitrage Funds. Here’s How They Work.

    Global companies continue to see increased consolidation in 2019, announcing more than 5,000 merger and acquisition deals worth over $650 billion. Merger arbitrage funds are one potential way to take advantage.

  • Reuters16 days ago

    Bayer board says pursuit of Monsanto was done diligently

    Bayer's non-executive board reaffirmed its support for top management's decision to acquire seed maker Monsanto last year, after losing high-profile lawsuits to U.S. plaintiffs who claimed Monsanto's Roundup weedkiller caused their cancer. In documents posted on the company's website on Monday, the non-executive supervisory board said an expert opinion it commissioned from lawfirm Linklaters found that Bayer's management had complied with their duties when acquiring Monsanto for $63 billion last year. "The Supervisory Board extensively discussed this expert opinion and based on this also comes to the conclusion that the Board of Management acted in compliance with its duties," it said.